Pharmacist Removed from Register Following Conviction for Supply of Controlled Drugs and Forgery
Date of Decision: February 20, 2025
Registrant's Role: Pharmacist
Allegations:
- Supply of a controlled drug (Class C) on multiple occasions
- Making an implement for forgery with intent
Outcome: Removal from the GPhC register
GPhC Standards Breached:
- Standard 1 – Provide person-centred care
- Standard 4 – Maintain, develop and use professional knowledge and skills
- Standard 6 – Behave in a professional manner
Case Summary
The General Pharmaceutical Council (GPhC) Fitness to Practise Committee investigated the registrant’s fitness to practise following convictions for the unlawful supply of controlled drugs and forgery. The case was triggered by an investigation by the Medicines and Healthcare products Regulatory Agency (MHRA), which found that between 2014 and 2017, the registrant had:
- Supplied over 27 million Class C controlled drug tablets (Diazepam, Zolpidem, and Zopiclone) without the required licences.
Continue Reading the Full Case
This case was published more than two weeks ago. A premium subscription is required to read the complete case summary.
- Full allegations considered by the GPhC/PSNI
- Panel findings and reasoning
- Outcome of the investigation
- Sanctions considered and imposed on the Pharmacist
- Key professional learning points
Original Case Document
The original determination document is available to registered users.